EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

COMIT-ANZ: an audit of cholangiocarcinoma and mixed hepatocellular carcinoma-cholangiocarcinoma outcomes for patients undergoing liver transplantation in Australia and New Zealand

Georgina E Riddiough, Kat Hall, Mandy Byrne, Kai Brown, Daniel Kilburn, Su Kah Goh, Matthew Marshall-Webb, Carlo Pulitano, Karen Chan, Adam Philipoff, Ali Nazaar, Eunice Lee

Frontiers in Transplantation · 07.08.2026 · 5

DOI: 10.3389/frtra.2026.1856922 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Transplantation, online erschienen am 07.08.2026. Verfasst von Georgina E Riddiough und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, The University of Melbourne, Austin Health Precinct, Heidelberg, VIC, Australia. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Recent ILTS guidance supports liver transplantation for patients with very small intrahepatic cholangiocarcinoma. This guidance was informed mainly by North American and European data. The applicability of these guidelines to the region of Australia and New Zealand is unknown.

Methods

A retrospective study was performed to measure clinical outcomes of liver transplantation in the ANZ region to ascertain the applicability of this new guidance to this region. Historic patients having undergone LT for known cholangiocarcinoma or incidentally detected cholangiocarcinoma or mixed type hepatocellular-cholangiocarcinomas on explant histology were identified via a national registry. Data was inputted from all transplant units within the ANZ region.

Results

We found that 64 patients had either knowingly or unknowingly been transplanted for cholangiocarcinoma or mixed type hepatocellular-cholangiocarcinoma in our region.

Discussion

Overall survival for patients with very small intrahepatic cholangiocarcinomas was 80%, in line with the current international data. We also report 5-year overall survival for patients with incidentally detected mixed tumours on explant histology was 68%.

Schlagwörter

Stichwörter der Autor:innen

cholangiocarcinomahepatocellular carcinomaliver neoplasmsliver transplantationsurvival

Autor:innen und Institutionen

  • Department of Surgery, The University of Melbourne, Austin Health Precinct, Heidelberg, VIC, Australia.
  • ANZLITR, Austin Health, Heidelberg, VIC, Australia.
  • Princess Alexandra Hospital, Woolloongabba, QLD, Australia.
  • Flinders Medical Centre, Bedford Park, SA, Australia.
  • Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
  • Sir Charles Gairdner Hospital, WA, Australia.

Zitieren

APA

Riddiough, G. E., Hall, K., Byrne, M., Brown, K., Kilburn, D., Goh, S. K., Marshall-Webb, M., Pulitano, C., Chan, K., Philipoff, A., Nazaar, A., & Lee, E. (2026). COMIT-ANZ: an audit of cholangiocarcinoma and mixed hepatocellular carcinoma-cholangiocarcinoma outcomes for patients undergoing liver transplantation in Australia and New Zealand. Frontiers in Transplantation, 5. https://doi.org/10.3389/frtra.2026.1856922

Vancouver

Riddiough GE, Hall K, Byrne M, Brown K, Kilburn D, Goh SK, et al. COMIT-ANZ: an audit of cholangiocarcinoma and mixed hepatocellular carcinoma-cholangiocarcinoma outcomes for patients undergoing liver transplantation in Australia and New Zealand. Frontiers in Transplantation. 2026;5. doi:10.3389/frtra.2026.1856922

BibTeX
@article{Riddiough2026,
  author = {Riddiough, Georgina E and Hall, Kat and Byrne, Mandy and Brown, Kai and Kilburn, Daniel and Goh, Su Kah and Marshall-Webb, Matthew and Pulitano, Carlo and Chan, Karen and Philipoff, Adam and Nazaar, Ali and Lee, Eunice},
  title = {COMIT-ANZ: an audit of cholangiocarcinoma and mixed hepatocellular carcinoma-cholangiocarcinoma outcomes for patients undergoing liver transplantation in Australia and New Zealand},
  journal = {Frontiers in Transplantation},
  year = {2026},
  volume = {5},
  doi = {10.3389/frtra.2026.1856922}
}
Kostenlos starten →